Investor Relations

Insider Trades Filter

Buyer/Seller : 

Year :         Type :      

Announce Date [Date of Effective Change] Buyer/ Seller Name [Type*] S/ W/ U ** Bought/ (Sold) ('000) Price ($) After Trade Note
No. of Shares ('000) *** % Held ***
03/08/21
[30/07/21]
Fullerton Fund Investments Pte Ltd ("FFI") [SSH] S/U (0.000)  - 24,969 4.56 Note
Remarks
Issuance of 72,972,973 new Shares pursuant to the completion of the Proposed Acquisition (as defined in the Listed Issuer's announcement dated 30 June 2021), as announced by the Listed Issuer on 30 July 2021. Immediately after the transaction
No. of ordinary voting shares/units held: 0 (Direct Interest); 24968788 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 0.00000000 (Direct Interest); 4.56000000 (Deemed Interest)
FFI does not have any direct interest in Shares. There is no change in the number of Shares in which FFI has a deemed interest. FFI is filing this notification form to report a change in the percentage level of its deemed interest in Shares from 5.27% to 4.56% as a result of the issuance of 72,972,973 new Shares pursuant to the completion of the Proposed Acquisition (as defined in the Listed Issuer's announcement dated 30 June 2021), as announced by the Listed Issuer on 30 July 2021. FFI is deemed interested in Shares through Heliconia Capital and Heliconia Holdings as follows. (i) Vanda 1 holds 1.14% of Shares. (ii) Encyclia 1 holds 3.42% of Shares. (iii) Heliconia Capital has an interest in 4.56% of Shares held in aggregate by Vanda 1 and Encyclia 1 pursuant to Section 4 of the Securities and Futures Act by virtue of its authority to dispose of, or exercise control over the disposal of the Shares held by Vanda 1 and Encyclia 1. (iv) Heliconia Capital is a wholly owned subsidiary of Heliconia Holdings. (v) Heliconia Holdings is a wholly owned subsidiary of Seletar. (vi) Seletar is a wholly owned subsidiary of FFI. Heliconia Capital and Heliconia Holdings are independently managed Temasek portfolio companies. FFI is not involved in their business or operating decisions, including those regarding their positions in Shares. Temasek Holdings (Private) Limited is the holding company of Fullerton Fund Investments Pte Ltd, which is in turn the holding company of Seletar Fund Investments Pte Ltd. The percentage of interest immediately before the change is calculated on the basis of 473,633,025 Shares. The percentage of interest immediately after the change is calculated on the basis of 546,605,998 Shares. In this Notice, figures are rounded down to the nearest 0.01%.
03/08/21
[30/07/21]
Seletar Fund Investments Pte Ltd ("Seletar") [SSH] S/U (0.000)  - 24,969 4.56 Note
Remarks
Issuance of 72,972,973 new Shares pursuant to the completion of the Proposed Acquisition (as defined in the Listed Issuer's announcement dated 30 June 2021), as announced by the Listed Issuer on 30 July 2021. Immediately after the transaction
No. of ordinary voting shares/units held: 0 (Direct Interest); 24968788 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 0.00000000 (Direct Interest); 4.56000000 (Deemed Interest)
Seletar does not have any direct interest in Shares. There is no change in the number of Shares in which Seletar has a deemed interest. Seletar is filing this notification form to report a change in the percentage level of its deemed interest in Shares from 5.27% to 4.56% as a result of the issuance of 72,972,973 new Shares pursuant to the completion of the Proposed Acquisition (as defined in the Listed Issuer's announcement dated 30 June 2021), as announced by the Listed Issuer on 30 July 2021. Seletar is deemed interested in Shares through Heliconia Capital and Heliconia Holdings as follows. (i) Vanda 1 holds 1.14% of Shares. (ii) Encyclia 1 holds 3.42% of Shares. (iii) Heliconia Capital has an interest in 4.56% of Shares held in aggregate by Vanda 1 and Encyclia 1 pursuant to Section 4 of the Securities and Futures Act by virtue of its authority to dispose of, or exercise control over the disposal of the Shares held by Vanda 1 and Encyclia 1. (iv) Heliconia Capital is a wholly owned subsidiary of Heliconia Holdings. (v) Heliconia Holdings is a wholly owned subsidiary of Seletar. Heliconia Capital and Heliconia Holdings are independently managed Temasek portfolio companies. Seletar is not involved in their business or operating decisions, including those regarding their positions in Shares. Temasek Holdings (Private) Limited is the holding company of Fullerton Fund Investments Pte Ltd, which is in turn the holding company of Seletar Fund Investments Pte Ltd. The percentage of interest immediately before the change is calculated on the basis of 473,633,025 Shares. The percentage of interest immediately after the change is calculated on the basis of 546,605,998 Shares. In this Notice, figures are rounded down to the nearest 0.01%.
03/08/21
[30/07/21]
Temasek Holdings (Private) Limited ("Temasek") [SSH] S/U (0.000)  - 24,969 4.56 Note
Remarks
Issuance of 72,972,973 new Shares pursuant to the completion of the Proposed Acquisition (as defined in the Listed Issuer's announcement dated 30 June 2021), as announced by the Listed Issuer on 30 July 2021. Immediately after the transaction
No. of ordinary voting shares/units held: 0 (Direct Interest); 24968788 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 0.00000000 (Direct Interest); 4.56000000 (Deemed Interest)
Temasek does not have any direct interest in Shares. There is no change in the number of Shares in which Temasek has a deemed interest. Temasek is filing this notification form to report a change in the percentage level of its deemed interest in Shares from 5.27% to 4.56% as a result of the issuance of 72,972,973 new Shares pursuant to the completion of the Proposed Acquisition (as defined in the Listed Issuer's announcement dated 30 June 2021), as announced by the Listed Issuer on 30 July 2021. Temasek is deemed interested in Shares through Heliconia Capital and Heliconia Holdings as follows. (i) Vanda 1 Investments Pte. Ltd. ("Vanda 1") holds 1.14% of Shares. (ii) Encyclia 1 Investments Pte. Ltd. ("Encyclia 1") holds 3.42% of Shares. (iii) Heliconia Capital has an interest in 4.56% of Shares held in aggregate by Vanda 1 and Encyclia 1 pursuant to Section 4 of the Securities and Futures Act by virtue of its authority to dispose of, or exercise control over the disposal of the Shares held by Vanda 1 and Encyclia 1. (iv) Heliconia Capital is a wholly owned subsidiary of Heliconia Holdings. (v) Heliconia Holdings is a wholly owned subsidiary of Seletar Fund Investments Pte Ltd ("Seletar"). (vi) Seletar is a wholly owned subsidiary of Fullerton Fund Investments Pte Ltd ("FFI"). (vii) FFI is a wholly owned subsidiary of Temasek. Heliconia Capital and Heliconia Holdings are independently managed Temasek portfolio companies. Temasek is not involved in their business or operating decisions, including those regarding their positions in Shares. Temasek Holdings (Private) Limited is the holding company of Fullerton Fund Investments Pte Ltd, which is in turn the holding company of Seletar Fund Investments Pte Ltd. The percentage of interest immediately before the change is calculated on the basis of 473,633,025 Shares. The percentage of interest immediately after the change is calculated on the basis of 546,605,998 Shares. In this Notice, figures are rounded down to the nearest 0.01%.
02/08/21
[30/07/21]
Heliconia Capital Management Pte. Ltd. [SSH] S/U (0.000)  - 24,969 4.57 Note
Remarks
On 30 July 2021, Asian Healthcare Specialists Limited had completed the acquisition of the remaining 49.0% of Cornerstone Asia Health Pte. Ltd. and had issued and allotted 72,972,973 new shares to the vendors of Cornerstone Asia Health Pte. Ltd. Immediately after the transaction
No. of ordinary voting shares/units held: 0 (Direct Interest); 24968788 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 0.00000000 (Direct Interest); 4.57000000 (Deemed Interest)
On 30 July 2021, Asian Healthcare Specialists Limited had completed the acquisition of the remaining 49.0% of Cornerstone Asia Health Pte. Ltd. and had issued and allotted 72,972,973 new shares to the vendors of Cornerstone Asia Health Pte. Ltd. The shareholding percentage immediately before the transaction was calculated based on the issued share capital of Asian Healthcare Specialists Limited of 473,633,025 shares. The shareholding percentage immediately after the transaction was calculated based on the issued share capital of Asian Healthcare Specialists Limited of 546,605,998 shares.
02/08/21
[30/07/21]
Heliconia Holdings Pte. Ltd. [SSH] S/U (0.000)  - 24,969 4.57 Note
Remarks
On 30 July 2021, Asian Healthcare Specialists Limited had completed the acquisition of the remaining 49.0% of Cornerstone Asia Health Pte. Ltd. and had issued and allotted 72,972,973 new shares to the vendors of Cornerstone Asia Health Pte. Ltd. Immediately after the transaction
No. of ordinary voting shares/units held: 0 (Direct Interest); 24968788 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 0.00000000 (Direct Interest); 4.57000000 (Deemed Interest)
On 30 July 2021, Asian Healthcare Specialists Limited had completed the acquisition of the remaining 49.0% of Cornerstone Asia Health Pte. Ltd. and had issued and allotted 72,972,973 new shares to the vendors of Cornerstone Asia Health Pte. Ltd. The shareholding percentage immediately before the transaction was calculated based on the issued share capital of Asian Healthcare Specialists Limited of 473,633,025 shares. The shareholding percentage immediately after the transaction was calculated based on the issued share capital of Asian Healthcare Specialists Limited of 546,605,998 shares.
30/07/21
[30/07/21]
Ng Tay Meng [SSH] S/U 12,191  0.185 27,386 5.01 Note
Remarks
Allotment and issuance of 12,190,585 consideration shares in the capital of the Company at an issue price of S$0.185 as part satisfaction of the purchase consideration in connection with the 49.0% acquisition of Cornerstone Asia Health Pte. Ltd. by the Company. The consideration shares notified in this form does not include consideration shares which have been designated by Dr. Ng Tay Meng for allotment and issuance to business associates who have contributed to the success of the Cornerstone Asia Health Group. Immediately after the transaction
No. of ordinary voting shares/units held: 27386455 (Direct Interest); 0 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 5.01000000 (Direct Interest); 0.00000000 (Deemed Interest)
The percentage interest before the change was calculated based on 473,633,025 shares and the percentage interest after the change was calculated based on 546,605,998 shares upon the issuance of 72,972,973 consideration shares as announced on 30 July 2021 pursuant to the the acquisition of the remaining 49.0% interest in the Company's subsidiary, Cornerstone Asia Health Pte. Ltd. by the Company.
30/07/21
[30/07/21]
Khoo Shih Wee @ Lawrence Khoo [SSH] S/U 14,155  0.185 31,799 5.82 Note
Remarks
Allotment and issuance of 14,154,738 consideration shares in the capital of the Company at an issue price of S$0.185 as part satisfaction of the purchase consideration in connection with the 49.0% acquisition of Cornerstone Asia Health Pte. Ltd. by the Company. The consideration shares notified in this form does not include consideration shares which have been designated by Dr. Lawrence Khoo for allotment and issuance to business associates who have contributed to the success of the Cornerstone Asia Health Group. Immediately after the transaction
No. of ordinary voting shares/units held: 31798975 (Direct Interest); 0 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 5.82000000 (Direct Interest); 0.00000000 (Deemed Interest)
The percentage interest before the change was calculated based on 473,633,025 shares and the percentage interest after the change was calculated based on 546,605,998 shares upon the issuance of 72,972,973 consideration shares as announced on 30 July 2021 pursuant to the the acquisition of the remaining 49.0% interest in Asian Healthcare Specialists Limited's (the "Company") subsidiary, Cornerstone Asia Health Pte. Ltd. by the Company.
30/07/21
[30/07/21]
Ho Siew Hong [SSH] S/U 18,189  0.185 41,267 7.55 Note
Remarks
Allotment and issuance of 18,189,305 consideration shares in the capital of the Company at an issue price of S$0.185 as part satisfaction of the purchase consideration in connection with the 49.0% acquisition of Cornerstone Asia Health Pte. Ltd. by the Company. The consideration shares notified in this form does not include consideration shares which have been designated by Dr. Ho Siew Hong for allotment and issuance to business associates who have contributed to the success of the Cornerstone Asia Health Group. Immediately after the transaction
No. of ordinary voting shares/units held: 41267103 (Direct Interest); 0 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 7.55000000 (Direct Interest); 0.00000000 (Deemed Interest)
The percentage interest before the change was calculated based on 473,633,025 shares and the percentage interest after the change was calculated based on 546,605,998 shares upon the issuance of 72,972,973 consideration shares as announced on 30 July 2021 pursuant to the the acquisition of the remaining 49.0% interest in the Company's subsidiary, Cornerstone Asia Health Pte. Ltd. by the Company.
30/07/21
[30/07/21]
Lim Tet Chen Roy [SSH] S/U (0.000)  - 35,923 6.57 Note
Remarks
Allotment and issuance of 72,972,973 consideration shares in the capital of the Company at an issue price of S$0.185 as part satisfaction of the purchase consideration in connection with the 49.0% acquisition of Cornerstone Asia Health Pte. Ltd. by the Company. Immediately after the transaction
No. of ordinary voting shares/units held: 35922857 (Direct Interest); 0 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 6.57000000 (Direct Interest); 0.00000000 (Deemed Interest)
The percentage interest before the change was calculated based on 473,633,025 shares and the percentage interest after the change was calculated based on 546,605,998 shares upon the issuance of 72,972,973 consideration shares as announced on 30 July 2021 pursuant to the the acquisition of the remaining 49.0% interest in the Company's subsidiary, Cornerstone Asia Health Pte. Ltd. by the Company.
30/07/21
[30/07/21]
AHS Investments Holdings Pte. Ltd. [SSH] S/U (0.000)  - 243,100 44.47 Note
Remarks
Allotment and issuance of 72,972,973 consideration shares in the capital of the Company at an issue price of S$0.185 as part satisfaction of the purchase consideration in connection with the 49.0% acquisition of Cornerstone Asia Health Pte. Ltd. by the Company. Immediately after the transaction
No. of ordinary voting shares/units held: 235807000 (Direct Interest); 7293000 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 43.14000000 (Direct Interest); 1.33000000 (Deemed Interest)
AHS Investments Holdings Pte. Ltd. ("AHSIH") is deemed interested in 7,293,000 shares held by Dr. Lim Cheok Peng under a right of first refusal granted by Dr. Lim to AHSIH in respect of the 7,293,000 shares held by him. Accordingly, under Section 4 of the Securities and Futures Act ("SFA"), AHSIH is deemed interested in the shares held by Dr. Lim. The shareholders of AHSIH are Dr. Chin Pak Lin, Dr. Yue Wai Mun, Dr. Su Hsien Ching David and Dr. Tan Chyn Hong in equal proportions. Accordingly, each of Dr. Chin, Dr. Yue, Dr. Su and Dr. Tan is deemed interested in the shares that AHSIH is interested in by virtue of Section 4 of the SFA. The percentage interest before the change was calculated based on 473,633,025 shares and the percentage interest after the change was calculated based on 546,605,998 shares upon the issuance of 72,972,973 consideration shares as announced on 30 July 2021 pursuant to the the acquisition of the remaining 49.0% interest in Asian Healthcare Specialists Limited's (the "Company") subsidiary, Cornerstone Asia Health Pte. Ltd. by the Company. None of the substantial shareholders giving notice under this Form had any change in the number of shares that they are interested in and the change in interest arose solely from the issuance of new shares by the Company. As a result, the equity interest of the existing substantial shareholder has been diluted.
30/07/21
[30/07/21]
Chin Pak Lin [SSH] S/U (0.000)  - 243,100 44.47 Note
Remarks
Allotment and issuance of 72,972,973 consideration shares in the capital of the Company at an issue price of S$0.185 as part satisfaction of the purchase consideration in connection with the 49.0% acquisition of Cornerstone Asia Health Pte. Ltd. by the Company. Immediately after the transaction
No. of ordinary voting shares/units held: 0 (Direct Interest); 243100000 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 0.00000000 (Direct Interest); 44.47000000 (Deemed Interest)
Please refer to paragraph 8 and 9 of substantial shareholder A's notification above. Please refer to paragraph 9 of substantial shareholder A's notification above. Please refer to paragraph 12 of substantial shareholder A's notification above.
30/07/21
[30/07/21]
Su Hsien Ching David [SSH] S/U (0.000)  - 243,100 44.47 Note
Remarks
Allotment and issuance of 72,972,973 consideration shares in the capital of the Company at an issue price of S$0.185 as part satisfaction of the purchase consideration in connection with the 49.0% acquisition of Cornerstone Asia Health Pte. Ltd. by the Company. Immediately after the transaction
No. of ordinary voting shares/units held: 0 (Direct Interest); 243100000 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 0.00000000 (Direct Interest); 44.47000000 (Deemed Interest)
Please refer to paragraph 8 and 9 of substantial shareholder A's notification above. Please refer to paragraph 9 of substantial shareholder A's notification above. Please refer to paragraph 12 of substantial shareholder A's notification above.
30/07/21
[30/07/21]
Tan Chyn Hong [SSH] S/U (0.000)  - 243,100 44.47 Note
Remarks
Allotment and issuance of 72,972,973 consideration shares in the capital of the Company at an issue price of S$0.185 as part satisfaction of the purchase consideration in connection with the 49.0% acquisition of Cornerstone Asia Health Pte. Ltd. by the Company. Immediately after the transaction
No. of ordinary voting shares/units held: 0 (Direct Interest); 243100000 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 0.00000000 (Direct Interest); 44.47000000 (Deemed Interest)
Please refer to paragraph 8 and 9 of substantial shareholder A's notification above. Please refer to paragraph 9 of substantial shareholder A's notification above. Please refer to paragraph 12 of substantial shareholder A's notification above.
30/07/21
[30/07/21]
Yue Wai Mun [SSH] S/U (0.000)  - 243,100 44.47 Note
Remarks
Allotment and issuance of 72,972,973 consideration shares in the capital of the Company at an issue price of S$0.185 as part satisfaction of the purchase consideration in connection with the 49.0% acquisition of Cornerstone Asia Health Pte. Ltd. by the Company. Immediately after the transaction
No. of ordinary voting shares/units held: 0 (Direct Interest); 243100000 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 0.00000000 (Direct Interest); 44.47000000 (Deemed Interest)
Please refer to paragraph 8 and 9 of substantial shareholder A's notification above. Please refer to paragraph 9 of substantial shareholder A's notification above. Please refer to paragraph 12 of substantial shareholder A's notification above.
30/07/21
[30/07/21]
Cheng Ching Li [DIR] S/U 21,950  0.185 49,311 9.02 Note
Remarks
Allotment and issuance of 21,949,690 consideration shares in the capital of the Company at an issue price of S$0.185 as part satisfaction of the purchase consideration in connection with the 49.0% acquisition of Cornerstone Asia Health Pte. Ltd. by the Company. The consideration shares notified in this form does not include consideration shares which have been designated by Dr. Cheng Ching Li for allotment and issuance to business associates who have contributed to the success of the Cornerstone Asia Health Group. Immediately after the transaction
No. of ordinary voting shares/units held: 49310528 (Direct Interest); 0 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 9.02000000 (Direct Interest); 0.00000000 (Deemed Interest)
The percentage interest before the change was calculated based on 473,633,025 shares and the percentage interest after the change was calculated based on 546,605,998 shares upon the issuance of 72,972,973 consideration shares as announced on 30 July 2021 pursuant to the the acquisition of the remaining 49.0% interest in the Company's subsidiary, Cornerstone Asia Health Pte. Ltd. by the Company.
26/04/21
[26/04/21]
Ho Siew Hong [SSH] S/U (0.000)  - 23,078 4.87 Note
Remarks
Issuance of 17,700,000 ordinary shares by Asian Healthcare Specialists Limited (the "Company") as announced on 26 April 2021 pursuant to the completion of placement of the subscription shares in the capital of the Company. Immediately after the transaction
No. of ordinary voting shares/units held: 23077798 (Direct Interest); 0 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 4.87000000 (Direct Interest); 0.00000000 (Deemed Interest)
The percentage interest before the change was calculated based on 455,933,025 shares and the percentage interest after the change was calculated based on 473,633,025 shares upon the issuance of 17,700,000 new ordinary shares as announced on 26 April 2021 pursuant to the completion of placement of the subscription shares in the capital of the Company. None of the substantial shareholders giving notice under this Form had any change in the number of shares that they are interested in and the change in interest arose solely from the issuance of new shares by the Company. As a result, the equity interest of the existing substantial shareholder has been diluted.
26/04/21
[26/04/21]
Cheng Ching Li [SSH] S/U (0.000)  - 27,361 5.78 Note
Remarks
Issuance of 17,700,000 ordinary shares by Asian Healthcare Specialists Limited (the "Company") as announced on 26 April 2021 pursuant to the completion of placement of the subscription shares in the capital of the Company. Immediately after the transaction
No. of ordinary voting shares/units held: 27360838 (Direct Interest); 0 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 5.78000000 (Direct Interest); 0.00000000 (Deemed Interest)
The percentage interest before the change was calculated based on 455,933,025 shares and the percentage interest after the change was calculated based on 473,633,025 shares upon the issuance of 17,700,000 new ordinary shares as announced on 26 April 2021 pursuant to the completion of placement of the subscription shares in the capital of the Company. None of the substantial shareholders giving notice under this Form had any change in the number of shares that they are interested in and the change in interest arose solely from the issuance of new shares by the Company. As a result, the equity interest of the existing substantial shareholder has been diluted.
26/04/21
[26/04/21]
AHS Investments Holdings Pte. Ltd. [SSH] S/U (0.000)  - 243,100 51.33 Note
Remarks
Issuance of 17,700,000 ordinary shares by the Company as announced on 26 April 2021 pursuant to the completion of placement of the subscription shares in the capital of the Company. Immediately after the transaction
No. of ordinary voting shares/units held: 235807000 (Direct Interest); 7293000 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 49.79000000 (Direct Interest); 1.54000000 (Deemed Interest)
AHS Investments Holdings Pte. Ltd. ("AHSIH") is deemed interested in 7,293,000 shares held by Dr Lim Cheok Peng under a right of first refusal granted by Dr Lim to AHSIH in respect of the 7,293,000 shares held by him. Accordingly, under Section 4 of the Securities and Futures Act ("SFA"), AHSIH is deemed interested in the shares held by Dr Lim. The shareholders of AHSIH are Dr Chin Pak Lin, Dr Yue Wai Mun, Dr Su Hsien Ching David and Dr Tan Chyn Hong in equal proportions. Accordingly, each of Dr Chin, Dr Yue, Dr Su and Dr Tan is deemed interested in the shares that AHSIH is interested in by virtue of Section 4 of the SFA. The percentage interest before the change was calculated based on 455,933,025 shares and the percentage interest after the change was calculated based on 473,633,025 shares upon the issuance of 17,700,000 new ordinary shares as announced on 26 April 2021 pursuant to the completion of placement of the subscription shares in the capital of Asian Healthcare Specialists Limited (the "Company"). None of the substantial shareholders giving notice under this Form had any change in the number of shares that they are interested in and the change in interest arose solely from the issuance of new shares by the Company. As a result, the equity interest of the existing substantial shareholder has been diluted.
26/04/21
[26/04/21]
Chin Pak Lin [SSH] S/U (0.000)  - 243,100 51.33 Note
Remarks
Issuance of 17,700,000 ordinary shares by the Company as announced on 26 April 2021 pursuant to the completion of placement of the subscription shares in the capital of the Company. Immediately after the transaction
No. of ordinary voting shares/units held: 0 (Direct Interest); 243100000 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 0.00000000 (Direct Interest); 51.33000000 (Deemed Interest)
Please refer to paragraph 8 of substantial shareholder A's notification above. Please refer to paragraph 9 of substantial shareholder A's notification above. Please refer to paragraph 12 of substantial shareholder A's notification above.
26/04/21
[26/04/21]
Su Hsien Ching David [SSH] S/U (0.000)  - 243,100 51.33 Note
Remarks
Issuance of 17,700,000 ordinary shares by the Company as announced on 26 April 2021 pursuant to the completion of placement of the subscription shares in the capital of the Company. Immediately after the transaction
No. of ordinary voting shares/units held: 0 (Direct Interest); 243100000 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 0.00000000 (Direct Interest); 51.33000000 (Deemed Interest)
Please refer to paragraph 8 of substantial shareholder A's notification above. Please refer to paragraph 9 of substantial shareholder A's notification above. Please refer to paragraph 12 of substantial shareholder A's notification above.
26/04/21
[26/04/21]
Tan Chyn Hong [SSH] S/U (0.000)  - 243,100 51.33 Note
Remarks
Issuance of 17,700,000 ordinary shares by the Company as announced on 26 April 2021 pursuant to the completion of placement of the subscription shares in the capital of the Company. Immediately after the transaction
No. of ordinary voting shares/units held: 0 (Direct Interest); 243100000 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 0.00000000 (Direct Interest); 51.33000000 (Deemed Interest)
Please refer to paragraph 8 of substantial shareholder A's notification above. Please refer to paragraph 9 of substantial shareholder A's notification above. Please refer to paragraph 12 of substantial shareholder A's notification above.
26/04/21
[26/04/21]
Yue Wai Mun [SSH] S/U (0.000)  - 243,100 51.33 Note
Remarks
Issuance of 17,700,000 ordinary shares by the Company as announced on 26 April 2021 pursuant to the completion of placement of the subscription shares in the capital of the Company. Immediately after the transaction
No. of ordinary voting shares/units held: 0 (Direct Interest); 243100000 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 0.00000000 (Direct Interest); 51.33000000 (Deemed Interest)
Please refer to paragraph 8 of substantial shareholder A's notification above. Please refer to paragraph 9 of substantial shareholder A's notification above. Please refer to paragraph 12 of substantial shareholder A's notification above.
03/09/20
[03/09/20]
Fullerton Fund Investments Pte Ltd ("FFI") [SSH] S/U 24,969  0.160 24,969 5.47 Note
Remarks
Acquisition of Securities following conversion/exercise of rights, options, warrants or other convertibles

Immediately after the transaction
No. of ordinary voting shares/units held: 0 (Direct Interest); 24968788 (Deemed Interest)
As a percentage of total no. of ordinary voting shares/units: 0.00000000 (Direct Interest); 5.47000000 (Deemed Interest)
FFI does not have any direct interest in Shares.

FFI is filing this notification form to report a deemed interest in Shares due to the acquisition of 6,242,197 Shares by Vanda 1 and 18,726,591 Shares by Encyclia 1 on 3 September 2020 pursuant to a conversion of convertible bonds.

FFI is deemed interested in Shares through Heliconia Capital and Heliconia Holdings as follows.

(i) Vanda 1 holds 1.369% of Shares.
(ii) Encyclia 1 holds 4.107% of Shares.
(iii) Heliconia Capital has an interest in 5.476% of Shares held in aggregate by Vanda 1 and Encyclia 1 pursuant to Section 4 of the Securities and Futures Act by virtue of its authority to dispose of, or exercise control over the disposal of the Shares held by Vanda 1 and Encyclia 1.
(iv) Heliconia Capital is a wholly owned subsidiary of Heliconia Holdings.
(v) Heliconia Holdings is a wholly owned subsidiary of Seletar.
(vi) Seletar is a wholly owned subsidiary of FFI.

Heliconia Capital and Heliconia Holdings are independently managed Temasek portfolio companies. FFI is not involved in their business or operating decisions, including those regarding their positions in Shares.

Temasek Holdings (Private) Limited is the holding company of Fullerton Fund Investments Pte Ltd, which is in turn the holding company of Seletar Fund Investments Pte Ltd.

The percentage of interest immediately after the change is calculated on the basis of 455,933,025 Shares.

In this Notice, figures are rounded down to the nearest 0.01% or 0.001%, as the case may be.
03/09/20
[03/09/20]
Seletar Fund Investments Pte Ltd ("Seletar") [SSH] S/U 24,969  0.160 24,969 5.47 Note
Remarks
Acquisition of Securities following conversion/exercise of rights, options, warrants or other convertibles

Immediately after the transaction
No. of ordinary voting shares/units held: 0 (Direct Interest); 24968788 (Deemed Interest)
As a percentage of total no. of ordinary voting shares/units: 0.00000000 (Direct Interest); 5.47000000 (Deemed Interest)
Seletar does not have any direct interest in Shares.

Seletar is filing this notification form to report a deemed interest in Shares due to the acquisition of 6,242,197 Shares by Vanda 1 and 18,726,591 Shares by Encyclia 1 on 3 September 2020 pursuant to a conversion of convertible bonds.

Seletar is deemed interested in Shares through Heliconia Capital and Heliconia Holdings as follows.

(i) Vanda 1 holds 1.369% of Shares.
(ii) Encyclia 1 holds 4.107% of Shares.
(iii) Heliconia Capital has an interest in 5.476% of Shares held in aggregate by Vanda 1 and Encyclia 1 pursuant to Section 4 of the Securities and Futures Act by virtue of its authority to dispose of, or exercise control over the disposal of the Shares held by Vanda 1 and Encyclia 1.
(iv) Heliconia Capital is a wholly owned subsidiary of Heliconia Holdings.
(v) Heliconia Holdings is a wholly owned subsidiary of Seletar.

Heliconia Capital and Heliconia Holdings are independently managed Temasek portfolio companies. Seletar is not involved in their business or operating decisions, including those regarding their positions in Shares.

Temasek Holdings (Private) Limited is the holding company of Fullerton Fund Investments Pte Ltd, which is in turn the holding company of Seletar Fund Investments Pte Ltd.

The percentage of interest immediately after the change is calculated on the basis of 455,933,025 Shares.

In this Notice, figures are rounded down to the nearest 0.01% or 0.001%, as the case may be.
03/09/20
[03/09/20]
Temasek Holdings (Private) Limited ("Temasek") [SSH] S/U 24,969  0.160 24,969 5.47 Note
Remarks
Acquisition of Securities following conversion/exercise of rights, options, warrants or other convertibles

Immediately after the transaction
No. of ordinary voting shares/units held: 0 (Direct Interest); 24968788 (Deemed Interest)
As a percentage of total no. of ordinary voting shares/units: 0.00000000 (Direct Interest); 5.47000000 (Deemed Interest)
Temasek does not have any direct interest in Shares.

Temasek is filing this notification form to report a deemed interest in Shares due to the acquisition of 6,242,197 Shares by Vanda 1 Investments Pte. Ltd. ("Vanda 1") and 18,726,591 Shares by Encyclia 1 Investments Pte. Ltd. ("Encyclia 1") on 3 September 2020 pursuant to a conversion of convertible bonds.

Temasek is deemed interested in Shares through Heliconia Capital and Heliconia Holdings as follows.

(i) Vanda 1 holds 1.369% of Shares.
(ii) Encyclia 1 holds 4.107% of Shares.
(iii) Heliconia Capital has an interest in 5.476% of Shares held in aggregate by Vanda 1 and Encyclia 1 pursuant to Section 4 of the Securities and Futures Act by virtue of its authority to dispose of, or exercise control over the disposal of the Shares held by Vanda 1 and Encyclia 1.
(iv) Heliconia Capital is a wholly owned subsidiary of Heliconia Holdings.
(v) Heliconia Holdings is a wholly owned subsidiary of Seletar Fund Investments Pte Ltd ("Seletar").
(vi) Seletar is a wholly owned subsidiary of Fullerton Fund Investments Pte Ltd ("FFI").
(vii) FFI is a wholly owned subsidiary of Temasek.

Heliconia Capital and Heliconia Holdings are independently managed Temasek portfolio companies. Temasek is not involved in their business or operating decisions, including those regarding their positions in Shares.

Temasek Holdings (Private) Limited is the holding company of Fullerton Fund Investments Pte Ltd, which is in turn the holding company of Seletar Fund Investments Pte Ltd.

The percentage of interest immediately after the change is calculated on the basis of 455,933,025 Shares.

In this Notice, figures are rounded down to the nearest 0.01% or 0.001%, as the case may be.
03/09/20
[03/09/20]
Heliconia Capital Management Pte. Ltd. [SSH] S/U 24,969  0.160 24,969 5.48 Note
Remarks
Acquisition of Securities following conversion/exercise of rights, options, warrants or other convertibles

Immediately after the transaction
No. of ordinary voting shares/units held: 0 (Direct Interest); 24968788 (Deemed Interest)
As a percentage of total no. of ordinary voting shares/units: 0.00000000 (Direct Interest); 5.47600000 (Deemed Interest)
Vanda 1 Investments Pte. Ltd. ("Vanda 1") had on 3 September 2020 acquired 6,242,197 Shares. Heliconia Capital Management Pte. Ltd. ("Heliconia Capital") has the authority to dispose of, or exercise control over the disposal of, the 6,242,197 Shares held by Vanda 1.

Encyclia 1 Investments Pte. Ltd. ("Encyclia 1") had on 3 September 2020 acquired 18,726,591 Shares. Heliconia Capital has authority to dispose of, or exercise control over the disposal of, the 18,726,591 Shares held by Encyclia 1.

Heliconia Holdings Pte. Ltd. ("Heliconia Holdings") is the immediate holding company of Heliconia Capital.

Each of Heliconia Holdings and Heliconia Capital is deemed interested in the aggregate of 24,968,788 Shares held by Vanda 1 and Encyclia 1 under Section 4 of the Securities and Future Act (Cap. 289).

The shareholding percentages in this document are calculated based on the issued share capital of Asian Healthcare Specialists Limited of 455,933,025 Shares.
03/09/20
[03/09/20]
Heliconia Holdings Pte. Ltd. [SSH] S/U 24,969  0.160 24,969 5.48 Note
Remarks
Acquisition of Securities following conversion/exercise of rights, options, warrants or other convertibles

Immediately after the transaction
No. of ordinary voting shares/units held: 0 (Direct Interest); 24968788 (Deemed Interest)
As a percentage of total no. of ordinary voting shares/units: 0.00000000 (Direct Interest); 5.47600000 (Deemed Interest)
Vanda 1 Investments Pte. Ltd. ("Vanda 1") had on 3 September 2020 acquired 6,242,197 Shares. Heliconia Capital Management Pte. Ltd. ("Heliconia Capital") has the authority to dispose of, or exercise control over the disposal of, the 6,242,197 Shares held by Vanda 1.

Encyclia 1 Investments Pte. Ltd. ("Encyclia 1") had on 3 September 2020 acquired 18,726,591 Shares. Heliconia Capital has authority to dispose of, or exercise control over the disposal of, the 18,726,591 Shares held by Encyclia 1.

Heliconia Holdings Pte. Ltd. ("Heliconia Holdings") is the immediate holding company of Heliconia Capital.

Each of Heliconia Holdings and Heliconia Capital is deemed interested in the aggregate of 24,968,788 Shares held by Vanda 1 and Encyclia 1 under Section 4 of the Securities and Future Act (Cap. 289).

The shareholding percentages in this document are calculated based on the issued share capital of Asian Healthcare Specialists Limited of 455,933,025 Shares.
03/09/20
[03/09/20]
Ho Siew Hong [SSH] S/U (0.000)  - 23,078 5.06 Note
Remarks
Issuance of 24,968,788 ordinary shares by Asian Healthcare Specialists Limited (the "Company") as announced on 3 September 2020 pursuant to the completion of the conversion of zero-coupon convertible bonds in the aggregate principal amount of S$4,000,000 due in 2021. Immediately after the transaction
No. of ordinary voting shares/units held: 23077798 (Direct Interest); 0 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 5.06000000 (Direct Interest); 0.00000000 (Deemed Interest)
The percentage interest before the change was calculated based on 430,964,237 shares and the percentage interest after the change was calculated based on 455,933,025 shares upon the issuance of 24,968,788 new ordinary shares as announced on 3 September 2020 pursuant to the conversion of zero-coupon convertible bonds in the aggregate principal amount of S$4,000,000 due in 2021. None of the substantial shareholders giving notice under this Form had any change in the number of shares that they are interested in and the change in interest arose solely from the issuance of new shares by the Company. As a result, the equity interest of the existing substantial shareholder has been diluted.
03/09/20
[03/09/20]
Cheng Ching Li [SSH] S/U (0.000)  - 27,361 6.00 Note
Remarks
Issuance of 24,968,788 ordinary shares by Asian Healthcare Specialists Limited (the "Company") as announced on 3 September 2020 pursuant to the completion of the conversion of zero-coupon convertible bonds in the aggregate principal amount of S$4,000,000 due in 2021. Immediately after the transaction
No. of ordinary voting shares/units held: 27360838 (Direct Interest); 0 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 6.00000000 (Direct Interest); 0.00000000 (Deemed Interest)
The percentage interest before the change was calculated based on 430,964,237 shares and the percentage interest after the change was calculated based on 455,933,025 shares upon the issuance of 24,968,788 new ordinary shares as announced on 3 September 2020 pursuant to the conversion of zero-coupon convertible bonds in the aggregate principal amount of S$4,000,000 due in 2021. None of the substantial shareholders giving notice under this Form had any change in the number of shares that they are interested in and the change in interest arose solely from the issuance of new shares by the Company. As a result, the equity interest of the existing substantial shareholder has been diluted.
03/09/20
[03/09/20]
Lim Tet Chen Roy [SSH] S/U (0.000)  - 35,923 7.88 Note
Remarks
Issuance of 24,968,788 ordinary shares by Asian Healthcare Specialists Limited (the "Company") as announced on 3 September 2020 pursuant to the completion of the conversion of zero-coupon convertible bonds in the aggregate principal amount of S$4,000,000 due in 2021. Immediately after the transaction
No. of ordinary voting shares/units held: 35922857 (Direct Interest); 0 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 7.88000000 (Direct Interest); 0.00000000 (Deemed Interest)
The percentage interest before the change was calculated based on 430,964,237 shares and the percentage interest after the change was calculated based on 455,933,025 shares upon the issuance of 24,968,788 new ordinary shares as announced on 3 September 2020 pursuant to the conversion of zero-coupon convertible bonds in the aggregate principal amount of S$4,000,000 due in 2021. None of the substantial shareholders giving notice under this Form had any change in the number of shares that they are interested in and the change in interest arose solely from the issuance of new shares by the Company. As a result, the equity interest of the existing substantial shareholder has been diluted.
03/09/20
[03/09/20]
AHS Investments Holdings Pte. Ltd. [SSH] S/U (0.000)  - 243,100 53.32 Note
Remarks
Issuance of 24,968,788 ordinary shares by Asian Healthcare Specialists Limited (the "Company") as announced on 3 September 2020 pursuant to the completion of the conversion of zero-coupon convertible bonds in the aggregate principal amount of S$4,000,000 due in 2021. Immediately after the transaction
No. of ordinary voting shares/units held: 235807000 (Direct Interest); 7293000 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 51.72000000 (Direct Interest); 1.60000000 (Deemed Interest)
AHS Investments Holdings Pte. Ltd. ("AHSIH") is deemed interested in 7,293,000 shares held by Dr Lim Cheok Peng under a right of first refusal granted by Dr Lim to AHSIH in respect of the 7,293,000 shares held by him. Accordingly, under Section 4 of the Securities and Futures Act ("SFA"), AHSIH is deemed interested in the shares held by Dr Lim. The shareholders of AHSIH are Dr Chin Pak Lin, Dr Yue Wai Mun, Dr Su Hsien Ching David and Dr Tan Chyn Hong in equal proportions. Accordingly, each of Dr Chin, Dr Yue, Dr Su and Dr Tan is deemed interested in the shares that AHSIH is interested in by virtue of Section 4 of the SFA. The percentage interest before the change was calculated based on 430,964,237 shares and the percentage interest after the change was calculated based on 455,933,025 shares upon the issuance of 24,968,788 new ordinary shares as announced on 3 September 2020 pursuant to the conversion of zero-coupon convertible bonds in the aggregate principal amount of S$4,000,000 due in 2021. None of the substantial shareholders giving notice under this Form had any change in the number of shares that they are interested in and the change in interest arose solely from the issuance of new shares by the Company. As a result, the equity interest of the existing substantial shareholder has been diluted.
03/09/20
[03/09/20]
Chin Pak Lin [SSH] S/U (0.000)  - 243,100 53.32 Note
Remarks
Issuance of 24,968,788 ordinary shares by Asian Healthcare Specialists Limited (the "Company") as announced on 3 September 2020 pursuant to the completion of the conversion of zero-coupon convertible bonds in the aggregate principal amount of S$4,000,000 due in 2021. Immediately after the transaction
No. of ordinary voting shares/units held: 0 (Direct Interest); 243100000 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 0.00000000 (Direct Interest); 53.32000000 (Deemed Interest)
Please refer to paragraph 8 of substantial shareholder A's notification above. Please refer to paragraph 9 of substantial shareholder A's notification above. Please refer to paragraph 12 of substantial shareholder A's notification above.
03/09/20
[03/09/20]
Su Hsien Ching David [SSH] S/U (0.000)  - 243,100 53.32 Note
Remarks
Issuance of 24,968,788 ordinary shares by Asian Healthcare Specialists Limited (the "Company") as announced on 3 September 2020 pursuant to the completion of the conversion of zero-coupon convertible bonds in the aggregate principal amount of S$4,000,000 due in 2021. Immediately after the transaction
No. of ordinary voting shares/units held: 0 (Direct Interest); 243100000 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 0.00000000 (Direct Interest); 53.32000000 (Deemed Interest)
Please refer to paragraph 8 of substantial shareholder A's notification above. Please refer to paragraph 9 of substantial shareholder A's notification above. Please refer to paragraph 12 of substantial shareholder A's notification above.
03/09/20
[03/09/20]
Tan Chyn Hong [SSH] S/U (0.000)  - 243,100 53.32 Note
Remarks
Issuance of 24,968,788 ordinary shares by Asian Healthcare Specialists Limited (the "Company") as announced on 3 September 2020 pursuant to the completion of the conversion of zero-coupon convertible bonds in the aggregate principal amount of S$4,000,000 due in 2021. Immediately after the transaction
No. of ordinary voting shares/units held: 0 (Direct Interest); 243100000 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 0.00000000 (Direct Interest); 53.32000000 (Deemed Interest)
Please refer to paragraph 8 of substantial shareholder A's notification above. Please refer to paragraph 9 of substantial shareholder A's notification above. Please refer to paragraph 12 of substantial shareholder A's notification above.
03/09/20
[03/09/20]
Yue Wai Mun [SSH] S/U (0.000)  - 243,100 53.32 Note
Remarks
Issuance of 24,968,788 ordinary shares by Asian Healthcare Specialists Limited (the "Company") as announced on 3 September 2020 pursuant to the completion of the conversion of zero-coupon convertible bonds in the aggregate principal amount of S$4,000,000 due in 2021. Immediately after the transaction
No. of ordinary voting shares/units held: 0 (Direct Interest); 243100000 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 0.00000000 (Direct Interest); 53.32000000 (Deemed Interest)
Please refer to paragraph 8 of substantial shareholder A's notification above. Please refer to paragraph 9 of substantial shareholder A's notification above. Please refer to paragraph 12 of substantial shareholder A's notification above.
19/02/20
[19/02/20]
Ho Siew Hong [SSH] S/U 23,078  0.260 23,078 5.35 Note
Remarks
Issuance of 23,077,798 ordinary shares (the "Consideration Shares") out of 104,171,380 Consideration Shares issued by Asian Healthcare Specialists Limited (the "Company") as announced on 19 February 2020 pursuant to the completion of the acquisition of 51.0% of Cornerstone Asia Health Pte. Ltd. by the Company. Immediately after the transaction
No. of ordinary voting shares/units held: 23077798 (Direct Interest); 0 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 5.35000000 (Direct Interest); 0.00000000 (Deemed Interest)
The percentage interest was calculated based on 430,964,237 shares upon the (i) issuance of 104,171,380 Consideration Shares as announced on 19 February 2020 pursuant to the completion of the acquisition of 51.0% of Cornerstone Asia Health Pte. Ltd. by the Company and (ii) issuance of 900,000 ordinary shares as announced on 19 February 2020 pursuant to the AHS Performance Share Plan.
21/12/18
[28/11/18]
Lim Tet Chen Roy [SSH] S/U 35,893  - 35,923 11.02 Note
Remarks
Issue of Consideration Shares by Asian Healthcare Specialists Limited ("AHS") as announced on 28 November 2018 pursuant to the completion of the acquisition of Asian Anaesthesia Care Pte. Ltd. by AHS. Amount of consideration paid or received by Substantial Shareholder/Unitholder (excluding brokerage and stamp duties): S$10,050,000 Immediately after the transaction
No. of ordinary voting shares/units held: 35922857 (Direct Interest); 0 (Deemed Interest) As a percentage of total no. of ordinary voting shares/units: 11.02000000 (Direct Interest); 0.00000000 (Deemed Interest)
The percentage interests before the change were calculated based on 290,000,000 Shares and the percentage interests after the change were calculated based on 325,892,857 Shares upon the issue of the Consideration Shares as announced on 28 November 2018. Any discrepancies in the percentages listed and totals thereof are due to rounding.
* DIR - Director (include Directors of related companies)
SSH - Substantial Shareholder
COY - Company Share Buyback
TMRP - Trustee-Manager/Responsible Person
** S - Shares
W - Warrants
U - Units
R - Rights
*** Direct & Deemed Interests

Notes

  1. Only trades by directors, substantial shareholders and company share buy back are included in Insider Trades.